Monoclonal antibody treatments for paediatric severe asthma-outcomes, attitudes and adherence

被引：0
|
作者：
Sheppard, Megan [1 ]
Kevat, Ajay [2 ]
Owens, Louisa [1 ]
Gray, Melinda [1 ]
机构：
[1] Sydney Childrens Hosp, Sydney, NSW, Australia
[2] Queensland Childrens Hosp, Brisbane, Qld, Australia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Children; Severe asthma; Asthma; -; management;
D O I：
10.1183/13993003.congress-2021.PA3931
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3931
引用
收藏
页数：2
相关论文
共 24 条
  • [11] Parents' prioritised outcomes for trials investigating treatments for paediatric severe infection: a qualitative synthesis
    Woolfall, Kerry
    O'Hara, Caitlin
    Deja, Elizabeth
    Canter, Ruth
    Khan, Imran
    Mouncey, Paul
    Carter, Anjali
    Jones, Nicola
    Watkins, Jason
    Lyttle, Mark David
    Tume, Lyvonne
    Agbeko, Rachel
    Tibby, Shane M.
    Pappachan, John
    Thorburn, Kent
    Rowan, Kathryn M.
    Peters, Mark John
    Inwald, David
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (11) : 1077 - 1082
  • [12] Problem solving to improve adherence and asthma outcomes in urban adults with moderate or severe asthma: A randomized controlled trial
    Apter, Andrea J.
    Wang, Xingmei
    Bogen, Daniel K.
    Rand, Cynthia S.
    McElligott, Sean
    Polsky, Daniel
    Gonzalez, Rodalyn
    Priolo, Chantel
    Adam, Bariituu
    Geer, Sabrina
    Ten Have, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (03) : 516 - U122
  • [13] An Update on Monoclonal Antibody Therapy to Treat Moderate-to-Severe Asthma: Benefits, Choices, and Limitations
    Elliott, Matthew R.
    Grogan, Charles E.
    Marshall Jr, Gailen D.
    AMERICAN JOURNAL OF MEDICINE, 2023, 136 (08) : 738 - 744
  • [14] Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
    Busse, W
    Corren, J
    Lanier, BQ
    McAlary, M
    Fowler-Taylor, A
    Della Cioppa, G
    van As, A
    Gupta, N
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) : 184 - 190
  • [15] Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
    Agumadu, Vivian C.
    Ramphul, Kamleshun
    Mejias, Stephanie G.
    Sonaye, Ruhi
    Sombans, Shaheen
    Lohana, Petras
    CUREUS, 2018, 10 (08):
  • [16] Economic burden of severe asthma associated with blood eosinophil elevation before introduction of Monoclonal Antibody Therapy
    De Juana Izquierdo, Cristina
    Martinez-Moragon, Eva
    Climent, Maria
    Lluch, Inmaculada
    Chiner, Eusebi
    Acosta, Marta
    Esteve, Andrea
    Calvache, Sergio
    Jose Bueso, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [17] A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
    Gennaro, D'Amato
    Amedeo, Piccolo
    Antonello, Salzillo
    Paolo, Noschese
    Maria, D'Amato
    Gennaro, Liccardi
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2007, 1 (03) : 225 - 231
  • [18] Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective
    Jeimy, Samira
    Tsoulis, Michael William
    Hachey, Julie
    Kim, Harold
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [19] Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective
    Samira Jeimy
    Michael William Tsoulis
    Julie Hachey
    Harold Kim
    Allergy, Asthma & Clinical Immunology, 14
  • [20] Evaluation of bronchial hyperreactivity and other functional parameters in severe asthma patients treated with anti-interleukin-5 monoclonal antibody (IL5)
    Bini, Francesco
    Grassi, Noemi
    Visca, Dina
    De Lauretis, Angelo
    SpaneNoello, Antonio
    Vaghi, Adriano
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
123